228 results on '"Sun, Zhifu"'
Search Results
2. The FOXP3+ Pro-Inflammatory T Cell: A Potential Therapeutic Target in Crohn’s Disease
3. Hypoxia-Inducible Factor 1α Stabilization Restores Epigenetic Control of Nitric Oxide Synthase 1 Expression and Reverses Gastroparesis in Female Diabetic Mice
4. Host immunity and KLF 11 deficiency together promote fibrosis in a mouse model of endometriosis.
5. G9a Modulates Lipid Metabolism in CD4 T Cells to Regulate Intestinal Inflammation
6. Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer
7. Altered glucose metabolism of the olfactory-related cortices in anosmia patients with traumatic brain injury
8. An investigation of plasma cell-free RNA for the detection of colorectal cancer: From transcriptome marker selection to targeted validation.
9. RNF20 and RNF40 regulate vitamin D receptor-dependent signaling in inflammatory bowel disease
10. Prognostic value of olfactory evoked potentials in patients with post-infectious olfactory dysfunction
11. Wildlife detection and identification based on the improved YOLOv7
12. Evaluation of circulating cell-free DNA in cholestatic liver disease using liver-specific methylation markers
13. Differences in olfactory habituation between orthonasal and retronasal pathways
14. Corrigendum to “Host immunity and KLF 11 deficiency together promote fibrosis in a mouse model of endometriosis” [BBA - Mol. Basis of Dis. 1869 (2023) 166784]
15. Anaerobic Digestion of Municipal Sewage Sludge Integrated with Brewery Wastewater Treatment: Importance of Temperature and Mixing Ratio
16. Corrigendum to “Host immunity and KLF 11 deficiency together promote fibrosis in a mouse model of endometriosis” [BBA - Mol. Basis of Dis. 1869 (2023) 166784]
17. Disturbed microbiota-metabolites-immune interaction network is associated with olfactory dysfunction in patients with chronic rhinosinusitis
18. Supplementary Table 2 from Genetic Variants Associated with the Risk of Chronic Obstructive Pulmonary Disease with and without Lung Cancer
19. Data from Genetic Variants Associated with the Risk of Chronic Obstructive Pulmonary Disease with and without Lung Cancer
20. Supplementary Table 3 from Genetic Variants Associated with the Risk of Chronic Obstructive Pulmonary Disease with and without Lung Cancer
21. Supplementary Table 1 from Genetic Variants Associated with the Risk of Chronic Obstructive Pulmonary Disease with and without Lung Cancer
22. Data from Fine Mapping of Chromosome 6q23-25 Region in Familial Lung Cancer Families Reveals RGS17 as a Likely Candidate Gene
23. Supplementary Tables 1-4 from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy
24. Supplemental Figures 1-6 from New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice
25. Supplemental Table 2 from New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice
26. Supplementary Figure 1 from Increased miR-708 Expression in NSCLC and Its Association with Poor Survival in Lung Adenocarcinoma from Never Smokers
27. Supplementary Data from Discovery, Validation, and Application of Novel Methylated DNA Markers for Detection of Esophageal Cancer in Plasma
28. Translation on this Article from Fine Mapping of Chromosome 6q23-25 Region in Familial Lung Cancer Families Reveals RGS17 as a Likely Candidate Gene
29. Supplementary Figure 3C from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy
30. Supplementary Figure 2B from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy
31. Supplementary Figure 1C from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy
32. Supplementary Table 4D from Global Methylation Profiling for Risk Prediction of Prostate Cancer
33. Data from Genetic Variation Predicting Cisplatin Cytotoxicity Associated with Overall Survival in Lung Cancer Patients Receiving Platinum-Based Chemotherapy
34. Supplemental Table 1 from New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice
35. Data from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy
36. Supplemental legend from Pathways Impacted by Genomic Alterations in Pulmonary Carcinoid Tumors
37. Supplementary Table 1 from Increased miR-708 Expression in NSCLC and Its Association with Poor Survival in Lung Adenocarcinoma from Never Smokers
38. Supplementary Table 1D from Global Methylation Profiling for Risk Prediction of Prostate Cancer
39. Supplementary Table 2 from Increased miR-708 Expression in NSCLC and Its Association with Poor Survival in Lung Adenocarcinoma from Never Smokers
40. Supplementary Table 6 from Global Methylation Profiling for Risk Prediction of Prostate Cancer
41. Supplementary Figure 4A from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy
42. Supplementary Table 1 from Glutathione Pathway Genetic Polymorphisms and Lung Cancer Survival After Platinum-Based Chemotherapy
43. Supplementary Table 5 from Global Methylation Profiling for Risk Prediction of Prostate Cancer
44. Supplementary Figure 2 from Increased miR-708 Expression in NSCLC and Its Association with Poor Survival in Lung Adenocarcinoma from Never Smokers
45. Supplementary Table 2 from Global Methylation Profiling for Risk Prediction of Prostate Cancer
46. Supplementary Table 3 from Global Methylation Profiling for Risk Prediction of Prostate Cancer
47. Supplementary Figure 1, Table 1 from Genetic Variation Predicting Cisplatin Cytotoxicity Associated with Overall Survival in Lung Cancer Patients Receiving Platinum-Based Chemotherapy
48. Supplementary Table 3 from Increased miR-708 Expression in NSCLC and Its Association with Poor Survival in Lung Adenocarcinoma from Never Smokers
49. Figure S1 from Pathways Impacted by Genomic Alterations in Pulmonary Carcinoid Tumors
50. Supplementary Figure 3 from Increased miR-708 Expression in NSCLC and Its Association with Poor Survival in Lung Adenocarcinoma from Never Smokers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.